The new focus on manned missions to the moon and Mars presents countless pressing challenges, including keeping humans alive ...
May 5 (Reuters) - Cytokinetics said on Tuesday its experimental heart disease drug significantly improved symptoms of a genetic heart condition in a late-stage trial. Shares of the company were up 13.
2h
Both very low and very high heart rates are significantly associated with stroke risk, study finds
A study presented at the European Stroke Organization Conference (ESOC) 2026 suggests that both very low and very high ...
It seems like there's scary news about heart health everywhere. On highway billboards, in news alerts about celebrities and ...
The new focus on manned missions to the moon and Mars presents countless pressing challenges, including keeping humans alive in hostile environments.
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...
A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 suggests that both very low and very ...
Brand experts explain that wearable devices' reliability for metrics like distance, heart rate and sleep are continually ...
Beetroot juice doesn’t promise instant transformation, but within a week, the body begins to respond in subtle but measurable ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing ...
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its VitalFlow Transport Frame Air and Ground (AG) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results